Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001826466-24-000146
Filing Date
2024-11-12
Accepted
2024-11-12 10:05:10
Documents
44
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm   iXBRL 10-Q 385355
2 EXHIBIT-31.1 exhibit31-1.htm EX-31.1 7154
3 EXHIBIT-32.1 exhibit32-1.htm EX-32.1 3238
  Complete submission text file 0001826466-24-000146.txt   2197371

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE nkph-20240930.xsd EX-101.SCH 18274
5 XBRL CALCULATION FILE nkph-20240930_cal.xml EX-101.CAL 24497
6 XBRL DEFINITION FILE nkph-20240930_def.xml EX-101.DEF 78483
7 XBRL LABEL FILE nkph-20240930_lab.xml EX-101.LAB 158252
8 XBRL PRESENTATION FILE nkph-20240930_pre.xml EX-101.PRE 140371
47 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 203228
Mailing Address 2269 MERRIMACK VALLEY AVENUE HENDERSON NV 89044
Business Address 2269 MERRIMACK VALLEY AVENUE HENDERSON NV 89044 7023263615
NIKA PHARMACEUTICALS, INC (Filer) CIK: 0001145604 (see all company filings)

EIN.: 900292940 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56234 | Film No.: 241444625
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)